HLA-A and meningioma: The applied ranking criterion of “frequency” (number of positive samples for a given antigen in our cohort) for reported meningioma-exclusive HLA ligands is biased toward the most frequent HLA class I allotypes within the cohort (e.g., HLA-A*02).